SCT Annual Meeting Presentations & Videos

Discover SCT's Scientific Knowledge-Bank

  233 Learning Opportunities Found

Silbergleit et al
2013 (Boston) Annual Meeting
Trial of the Year Award
Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART)
Richard Saitz
2013 (Boston) Annual Meeting
Founders Lecture
Challenges for Health Behavior Trials from Design to Practice: The Example of Unhealthy Alcohol Use
Paul Wakim
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (3) Trial Monitoring (Interim analyses & sample-size recalculation)
Paul Wakim
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (5) Publication of Results
Michele Melia
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (4) Final Analysis & Subgroup Analysis (reject H0, p-value, correct, site-by-treatment interaction)
Paul Wakim
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (2) Analysis Plan (simple vs. complex, use of covariates, longitudinal models, handling missing data)
Michele Melia
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (1) Overview of Trial Design (hypothesis testing, sample size, power)
Karthik Venkatakrishnan
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (3) Drug-Drug Interactions and Pharmacogenomic Variation (Part 2 - Application in Therapuetics and Drug Development)
Karthik Venkatakrishnan
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (2) Drug-Drug Interactions and Pharmacogenomic Variation (Part 1 - Illustrated Examples of Principles)
Kevin Sweeney
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (4) Principles of Pharmacometrics
David Greenblatt
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (1) Pharmacokenetics
Peter Peduzzi
2013 (Boston) Annual Meeting
Fellows Presentation
Presentation of the Class of 2013 Fellows
Atul Butte
2013 (Boston) Annual Meeting
Curtis Meinert Lecture
Transforming a Trillion Points of Data into Diagnostics, Therapeutics, and New Insights into Disease
Dale Williams
2013 (Boston) Annual Meeting
Special Presentation
35 Years of SCT
Anne Lindblad
2013 (Boston) Annual Meeting
Presidential Welcome
Natalie Nardone
2013 (Boston) Annual Meeting
Contributed Session
A Bayesian Analysis of a Clinical Trial for Treatment of Uveitis
Marie-Karelle RIVIERE
2013 (Boston) Annual Meeting
Contributed Session
A Bayesian Dose-finding Design for Clinical Trials Combining a Cytotoxic Agent with a Biological Agent
Donald Chi
2013 (Boston) Annual Meeting
Contributed Session
A community-based clinical trial to improve the oral health-related knowledge and self-efficacy of Korean-American caregivers of young children
TAO WANG
2013 (Boston) Annual Meeting
Contributed Session
A COMPARISON OF THE 3+3 DESIGN, THE ROLLING SIX DESIGN, THE CRM, AND THE MODIFIED CRM IN PHASE I CLINICAL TRIALS USING DISCRETE EVENT SIMULATION
Cody Chiuzan
2013 (Boston) Annual Meeting
Contributed Session
A likelihood-based approach to selecting doses with acceptable toxicity in a standard algorithm-based phase I cancer trial
cathy yang
2013 (Boston) Annual Meeting
Contributed Session
A Multi-system Setup for Developing Electronic Case Report Forms (e-CRFs)
KyungMann Kim
2013 (Boston) Annual Meeting
Contributed Session
A New Paradigm for Large, Simple Trials Based on Electronic Health Records
Richard Emsley
2013 (Boston) Annual Meeting
Contributed Session
A NEW TRIAL DESIGN FULLY INTEGRATING BIOMARKER INFORMATION FOR THE EVALUATION OF TREATMENT-EFFECT MECHANISMS IN PERSONALISED MEDICINE
Jin Zhang
2013 (Boston) Annual Meeting
Contributed Session
A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Among and Within Patients
Karisse Torres
2013 (Boston) Annual Meeting
Contributed Session
A Practical Approach to Estimating Effect of Change in Recruitment Duration, Cluster Size, and Number of Cluster Units on Statistical Power of a Cluster Randomized Trial
Jonathan Wright
2013 (Boston) Annual Meeting
Contributed Session
A PRACTICAL EXAMPLE OF APPROACHES TAKEN TO HANDLE COMPLEXITIES IN MULTIPLE EVENTS ANALYSIS
Tracy Bergemann
2013 (Boston) Annual Meeting
Contributed Session
A smooth estimate of the hazard ratio over a continuous covariate
MI MI KO
2013 (Boston) Annual Meeting
Contributed Session
A Study of Tongue and Pulse Diagnosis in Traditional Korean Medicine for the Stroke Patients Based on Quantification Theory Type II
Jonathan Cook
2013 (Boston) Annual Meeting
Contributed Session
A systematic review of methods for specifying the target difference in randomised controlled trials (DELTA review)
Theodore Karrison
2013 (Boston) Annual Meeting
Contributed Session
A VERSATILE TEST FOR COMPARING SURVIVAL CURVES BASED ON WEIGHTED LOG-RANK STATISTICS
Qiang Zhang
2013 (Boston) Annual Meeting
Contributed Session
A Weibull model for the correlation between progression-free survival and overall survival
Spencer Hey
2013 (Boston) Annual Meeting
Contributed Session
Accumulating Evidence and Research Organization (AERO) Model: A New Tool for Representing, Analyzing, and Planning A Translational Research Program
Brian Hobbs
2013 (Boston) Annual Meeting
Contributed Session
Adaptive adjustment of the randomization ratio using historical control data
Neal Oden
2013 (Boston) Annual Meeting
Contributed Session
Algorithms for inference following Bernoulli random walks with desirable absorbing boundaries
Cassidy Conner
2013 (Boston) Annual Meeting
Contributed Session
An analysis of data changes in response to real-time protocol violation (PV) alerts in an Electronic Data Capture (EDC) system
Kellee Miller
2013 (Boston) Annual Meeting
Contributed Session
An Assessment of Agreement between Self-reported and Clinic-reported Data Collection in a Type 1 Diabetes Clinic Registry
Gregory Levin
2013 (Boston) Annual Meeting
Contributed Session
An Evaluation of Inferential Procedures for Adaptive Clinical Trial Designs with Pre-specified Rules for Modifying the Sample Size
Jonathan Hartzel
2013 (Boston) Annual Meeting
Contributed Session
Application of a Seamless Phase II/III, Group-Sequential Design in the Development of a S. aureus Vaccine
Valerie Durkalski
2013 (Boston) Annual Meeting
Contributed Session
ASSESSING THE ‘SUCCESS’ OF THE BLIND IN SHAM-CONTROLLED RANDOMIZED CLINICAL TRIALS AND THE IMPACT ON TREATMENT EFFECT
Yumi Kubo
2013 (Boston) Annual Meeting
Contributed Session
Assessing the actual treatment benefit with non-adherence to study drug in a large randomized trial
JIAJING XU
2013 (Boston) Annual Meeting
Contributed Session
Bayesian Model Selection Approach to Dose Finding in Two-stage Clinical Trials for Cytostatic Agents.
Sheng Luo
2013 (Boston) Annual Meeting
Contributed Session
Bayesian Multiple Imputation for Missing Multivariate Longitudinal Data from a Parkinson's Disease Clinical Trial
Christina Tittsworth
2013 (Boston) Annual Meeting
Contributed Session
Beware of Too Many Cooks in the Kitchen: Concocting the Perfect Query Recipe
Adrielle Houweling
2013 (Boston) Annual Meeting
Contributed Session
BLINDING STRATEGIES AND THEIR EFFECT IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL (RCT) OF ELASTIC COMPRESSION STOCKINGS (ECS) FOR PREVENTION OF POST-THROMBOTIC SYNDROME (PTS)
Robert Parker
2013 (Boston) Annual Meeting
Contributed Session
Can We Explain the Drop in Efficacy in as Drugs Progress to Later Stage Clinical Trials?
Adrian Gheorghe
2013 (Boston) Annual Meeting
Contributed Session
Center selection in clinical trials and the generalizability of results: a mixed methods study
Joerg Hasford
2013 (Boston) Annual Meeting
Contributed Session
CHALLENGES OF COMPOSITE ENDPOINTS FOR TRIAL EXECUTION, STATISTICAL ANALYSIS AND INTERPRETATION
Jenny Tseng
2013 (Boston) Annual Meeting
Contributed Session
Challenges in Analyzing Safety Data in a Phase III Trial to Evaluate the Safety of Extended Regimen of Nevirapine (NVP) in Infants Born to HIV-infected Mothers to Prevent Vertical HIV Transmission during Breastfeeding (HPTN 046)
Shelly Lensing
2013 (Boston) Annual Meeting
Contributed Session
Challenges in Quantifying Physical Activity with Tri-Axial Accelerometers in a Randomized Controlled Clinical Trial of a Lifestyle Intervention in Sedentary Older Women
Jessica Stucker
2013 (Boston) Annual Meeting
Contributed Session
Challenges of Providing Medical Results to Participants in Field-Based Studies: Experiences in the Gulf Long-Term Follow-Up Study (GuLF STUDY)
Alice Sheffet
2013 (Boston) Annual Meeting
Contributed Session
CHARACTERISTICS OF PARTICIPANTS AGREEING TO LONG-TERM (UP TO TEN YEARS) FOLLOW-UP IN A LARGE RANDOMIZED CLINICAL TRIAL
uma kher
2013 (Boston) Annual Meeting
Contributed Session
Characterization of bias between validated assays using regression methods
Xiaoyu Jia
2013 (Boston) Annual Meeting
Contributed Session
Characterization of two-stage likelihood continual reassessment method
Anne Zielinski
2013 (Boston) Annual Meeting
Contributed Session
Clinical Data from Everyone
Dawn Hunt
2013 (Boston) Annual Meeting
Contributed Session
Clinical Monitoring: A Collaborative Approach. Process and Outcomes of Implementing a Clinical Monitoring Program in the National Institute of Environmental Health Sciences Clinical Research Unit
Henian Chen
2013 (Boston) Annual Meeting
Contributed Session
Collecting Data from Nonrespondents in Quality of Life: Benefits and Implications
Karen Briggs
2013 (Boston) Annual Meeting
Contributed Session
Common Mistakes to Avoid in Clinical Trial Case Report Form Design
Ashley Pinckney
2013 (Boston) Annual Meeting
Contributed Session
Comparability of CTCAE grading and clinical significance in abnormal clinical laboratory results
Christina Yap
2013 (Boston) Annual Meeting
Contributed Session
Comparing the implementation of a Modified Continual Reassessment Method to a Traditional 3+3 Design in a Phase I Acute Myeloid Leukaemia Trial
Amit Chowdhry
2013 (Boston) Annual Meeting
Contributed Session
Comparison of a Linear Mixed Effects Model and Mixed Model Repeated Measures for Analyzing Incomplete Longitudinal Data in Clinical Trials
Tsung Yu
2013 (Boston) Annual Meeting
Contributed Session
Comparison of benefits and harms of roflumilast in patients with moderate to severe chronic obstructive pulmonary disease and a history of exacerbations
Greg Ball
2013 (Boston) Annual Meeting
Contributed Session
CONTINUOUS SAFETY MONITORING FOR RANDOMIZED CONTROLLED CLINICAL TRIALS WITH BLINDED TREATMENT INFORMATION
zhengjia Chen
2013 (Boston) Annual Meeting
Contributed Session
Continuous Tumor Size Change Percentage and Progression Free Survival as Endpoint of the First and Second Stage Respectively in a Novel Double Screening Phase II Design
Valerie Stevenson
2013 (Boston) Annual Meeting
Contributed Session
Correlation of a Form-based Versus Item-based Metric of Data Accuracy In Case Report Form Completion in a Clinical Trial Network
Siyan Xu
2013 (Boston) Annual Meeting
Contributed Session
Covariate effect on constancy assumption in active controlled clinical trials
akiko kada
2013 (Boston) Annual Meeting
Contributed Session
Creating a new Scoring Endpoint of Cardiac Events and Questionnaire-based Heart Failure Symptom
Ying Lu
2013 (Boston) Annual Meeting
Contributed Session
Cross-sectional and short-term follow-up design to retrospectively estimate odds ratios
Ellen Peskin
2013 (Boston) Annual Meeting
Contributed Session
CURRENT PRACTICES IN REMOTE MONITORING VISITS
Tingting Li
2013 (Boston) Annual Meeting
Contributed Session
DATA MONITORING COMMITTEES IN CHINA
Jessica Stortz
2013 (Boston) Annual Meeting
Contributed Session
DELEGATION LOGS IN A REGULATED CLINICAL TRIAL INVOLVING MULTIDISCIPLINARY TEAMS
Cécile Chauvel
2013 (Boston) Annual Meeting
Contributed Session
Design and analysis of a clinical trial in which mild to moderate non-proportional hazards is a possibility
Andrew Forbes
2013 (Boston) Annual Meeting
Contributed Session
Design and analysis of cluster randomized crossover trials with binary outcomes with application to intensive care research
Katherine Huppler Hullsiek
2013 (Boston) Annual Meeting
Contributed Session
DESIGN OF AN INTERNATIONAL CLUSTER-RANDOMIZED TRIAL COMPARING TWO DATA MONITORING PRACTICES
Semhar Ogbagaber
2013 (Boston) Annual Meeting
Contributed Session
Design of Sequentially Randomized Trials for Testing Adaptive Treatment Strategies
Siew Wan Hee
2013 (Boston) Annual Meeting
Contributed Session
DESIGNING A SERIES OF HYBRID TRIALS WITH CONTINUOUS OUTCOMES
Johanna Sanchez
2013 (Boston) Annual Meeting
Contributed Session
DEVELOPING AN ONLINE TRAINING MODULE FOR MULTICENTRE TRIALS
Roberta Constantine
2013 (Boston) Annual Meeting
Contributed Session
Developing Approaches for Randomization within the Mini-Sentinel Distributed Database
Danielle Chandler
2013 (Boston) Annual Meeting
Contributed Session
DEVELOPMENT OF A PARENT INFORMATIONAL VIDEO TO AID RECRUITMENT IN A PEDIATRIC SURGICAL RANDOMIZED TRIAL
John Podoba
2013 (Boston) Annual Meeting
Contributed Session
DEVELOPMENT OF AN ALGORITHM AND A WEB-BASED SOFTWARE MODULE FOR SINGLE AND MULTI-STAGE PATIENT ENROLLMENT PROCESSES FOR WEB RANDOMIZATION
Sherrie Whisler
2013 (Boston) Annual Meeting
Contributed Session
Development of Data Diamond Reporting System
Peter Merrill
2013 (Boston) Annual Meeting
Contributed Session
Dichotomizing Partial Compliance and Increased Participant Burden in Factorial Designs: The Performance of Four Non-Compliance Methods
Scott Rushing
2013 (Boston) Annual Meeting
Contributed Session
Digital Data Collection – The LIFE Experience
Graeme MacLennan
2013 (Boston) Annual Meeting
Contributed Session
Do advance telephone calls ahead of reminder questionnaires increase response rate in non-responders compared to questionnaire reminders only: The RECORD Phone Trial.
Leah Griffin
2013 (Boston) Annual Meeting
Contributed Session
Dynamic Web-Based Management of a Lifestyle Intervention: The Study of Novel Approaches to Prevention Clinical Trial
Peter Thall
2013 (Boston) Annual Meeting
Contributed Session
Dysfunctional Conventions in Clinical Trials: Some Bayesian Alternatives
Sarah Gaussoin
2013 (Boston) Annual Meeting
Contributed Session
EFFECTIVENESS OF A MID-TRIAL TRAINING SESSION FOR MONITORING SERIOUS ADVERSE EVENTS: EXPERIENCE IN ACTION FOR HEALTH IN DIABETES (LOOK AHEAD) STUDY
DONG VO
2013 (Boston) Annual Meeting
Contributed Session
Electronic Conversion and Archiving of clinical trial paper records
Martina Mueller
2013 (Boston) Annual Meeting
Contributed Session
Enhanced protocol compliance in a complex clinical trial using web-based response adaptive treatment instructions
Ainy Zahid
2013 (Boston) Annual Meeting
Contributed Session
ENSURING ACCURATE OUTCOMES REVIEW FOR DATA ANALYSIS
Asma Qureshi
2013 (Boston) Annual Meeting
Contributed Session
ENSURING COMPLIANCE TO GOOD CLINICAL PRACTICE REQUIREMENTS IN MULTI-CENTRE STUDIES
Ye Cui
2013 (Boston) Annual Meeting
Contributed Session
Escalation with Overdose Control using All Toxicities and Time to Toxicity Data for Cancer Phase I Clinical Trials
Ruediger Laubender
2013 (Boston) Annual Meeting
Contributed Session
Estimating heterogeneous treatment effects from data generated in randomized controlled trials based on the parallel group design using predictive baseline covariates.
Dorothee Arenz
2013 (Boston) Annual Meeting
Contributed Session
Estimating Site Costs Prior to Conducting Clinical Trials – A Study Site Budgeting Tool
Jae Eun Lee
2013 (Boston) Annual Meeting
Contributed Session
Evaluating Potential Impact of Modified Eligibility Criteria on Enrollment and Study Results in Cardiovascular Clinical Trials
Leslie McClure
2013 (Boston) Annual Meeting
Contributed Session
Evaluating the Impact of Increasing the Sample Size in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial: Hindsight is 20/20
Rebecca Elmore
2013 (Boston) Annual Meeting
Contributed Session
EVALUATION OF RETENTION RATES BY DEMOGRAPHIC CHARACTERISTICS IN THE ENVIRONMENTAL POLYMORPHISM REGISTRY (EPR)
Janice Pogue
2013 (Boston) Annual Meeting
Contributed Session
Evidence Informed Missing Data Imputation for Cognitive Function Tests within RCTs
L. Suzanne Firrell
2013 (Boston) Annual Meeting
Contributed Session
Evolving Best Practices to Meet the Demands of Revolutionizing Research at Coordinating Centers
John Hermos
2013 (Boston) Annual Meeting
Contributed Session
FACTORS ASSOCIATED WITH RETENTION OF AFRICAN-AMERICAN AND WHITE PARTICIPANTS IN A PROSTATE CANCER PREVENTION TRIAL
Charles Heisey
2013 (Boston) Annual Meeting
Contributed Session
FAMILY FORUMS: A MODEL FOR PARTICIPANT EDUCATION AND ENGAGEMENT
Louise Flanagan
2013 (Boston) Annual Meeting
Contributed Session
From late phase to early phase: experiences of establishing a disease-specific early phase trials unit
Elizabeth Nelson
2013 (Boston) Annual Meeting
Contributed Session
FROM THE LAB TO THE NETWORK: MANAGEMENT OF EXPERIMENTAL, CLINICAL AND SPECIMEN DATA USING THE OPEN SOURCE LABKEY SERVER SYSTEM
Sharon Yeatts
2013 (Boston) Annual Meeting
Contributed Session
Futility Design Incorporating Concurrent Controls: A Variation on the Phase II Trial Design
Elizabeth Sugar
2013 (Boston) Annual Meeting
Contributed Session
Graphical Methods for Monitoring Clinical Trial Data
David Smith
2013 (Boston) Annual Meeting
Contributed Session
Has the Voluntary Harmonisation Procedure been a successful attempt to streamline the approval process for multinational clinical trials in the EU? Examining applicants’ experience to date with the GTFG’s initiative.
Yannan Jiang
2013 (Boston) Annual Meeting
Contributed Session
Heart Exercise and Remote Technologies (HEART): A Randomized Controlled Trial
J Athene Lane
2013 (Boston) Annual Meeting
Contributed Session
HOW DO TRIAL STEERING COMMITTEES AND MANAGEMENT GROUPS CONTRIBUTE TO TRIAL CONDUCT?
Deborah Toyota
2013 (Boston) Annual Meeting
Contributed Session
How Much is Enough: A Risk Based Approach to Analysis Verification
Phyllis Silverman
2013 (Boston) Annual Meeting
Contributed Session
How to Get the Most Out of Your Courtship with FDA - An FDA Medical Device Reviewer's Perspective
Erik Doffagne
2013 (Boston) Annual Meeting
Contributed Session
IDENTIFYING ATYPICAL SITES WITH CENTRAL STATISTICAL MONITORING
Ming-Wen An
2013 (Boston) Annual Meeting
Contributed Session
Identifying continuous Phase II endpoints using RECIST 1.1 data warehouse measurements
Rajnish Mago
2013 (Boston) Annual Meeting
Contributed Session
Identifying Potential Adverse Effects by Patients’ Ratings: A Proof-of-Concept Study of a Novel Approach
Moonseong Heo
2013 (Boston) Annual Meeting
Contributed Session
Impact of subject attrition on sample size determinations for longitudinal cluster randomized clinical trials
Gary Gensler
2013 (Boston) Annual Meeting
Contributed Session
IMPLEMENTING A CENTRAL MONITORING PROCESS
Chad Shenk
2013 (Boston) Annual Meeting
Contributed Session
Implementing Clinical Trials Methodology into the Everyday Care of Abused Children
Colin Everett
2013 (Boston) Annual Meeting
Contributed Session
Implementing unbalanced assignment by minimisation
Brandi Meeks
2013 (Boston) Annual Meeting
Contributed Session
Improved Recruitment Rates in a Randomized Controlled Trial of Acute Myocardial Infarction through use of a Web-based Interface for Central Randomization
Dena Cohen
2013 (Boston) Annual Meeting
Contributed Session
INCORPORATING EMERGING THERAPIES INTO ONGOING RANDOMISED CLINICAL TRIALS
Jing Zhou
2013 (Boston) Annual Meeting
Contributed Session
Information-Based Sample Size Re-estimation in Group Sequential Design for Longitudinal Trials
Jason Griffin
2013 (Boston) Annual Meeting
Contributed Session
INTEGRATING STUDY DATA FROM MULTIPLE SOURCES USING SQL SERVER - THE ACCORDION STUDY
Zhibo Wang
2013 (Boston) Annual Meeting
Contributed Session
Interactive Statistical Software for Estimating the Operating Characteristics of Cancer Phase I Clinical Trial Designed with Standard 3+3 Algorithm
Ashutosh Ranjan
2013 (Boston) Annual Meeting
Contributed Session
INTERNAL PILOT DESIGN FOR CLUSTER RANDOMIZED TRIALS WITH UNEQUAL CLUSTER SIZES
Joseph Rausch
2013 (Boston) Annual Meeting
Contributed Session
Investigating Treatment Effect Variability in Randomized Longitudinal Clinical Trials
Bergman Sam
2013 (Boston) Annual Meeting
Contributed Session
KEY DATA EDITING FEATURES OF THE BSC DATA MANAGEMENT SYSTEM FOR COORDINATING CENTERS IN MULTI-CENTER CLINICAL TRIALS
Patrick Chassaigne
2013 (Boston) Annual Meeting
Contributed Session
Leveraging IT tools for Comparative Effectiveness Research
Megan Smith
2013 (Boston) Annual Meeting
Contributed Session
Likelihood-based methods for the prediction of endpoint occurrences in clinical trials
NICHOLAS COUNSELL
2013 (Boston) Annual Meeting
Contributed Session
LITERATURE REVIEW TO COMPARE INTERIM AND FINAL RESULTS OF PUBLISHED CLINICAL TRIALS
Mae Gordon
2013 (Boston) Annual Meeting
Contributed Session
Locating Study Participants 5 years After Closeout
Catherine Lowe
2013 (Boston) Annual Meeting
Contributed Session
Logistical considerations for independent review of patient imaging for quality assurance or real time reporting in oncology clinical trials
Zhibao Mi
2013 (Boston) Annual Meeting
Contributed Session
Lumping and Splitting Approach to Analyzing High Dimensional Sparse Counts Data
Steven Ramsey
2013 (Boston) Annual Meeting
Contributed Session
Managing Performance of Field Staff in the Gulf Long-Term Follow-up Study (GuLF STUDY)
Maiken Pontoppidan
2013 (Boston) Annual Meeting
Contributed Session
Measuring mental health, attachment, and behavioural development in 0-1 year old infants and their parents
Valerie Brueton
2013 (Boston) Annual Meeting
Contributed Session
Measuring the impact of methodological research at the UK Medical Research Council Clinical Trials Unit
Abigail Shoben
2013 (Boston) Annual Meeting
Contributed Session
Meta-analysis of one outcome from group sequential trials with composite outcomes: Are standard methods appropriate?
Sean Neal
2013 (Boston) Annual Meeting
Contributed Session
Minimizing Reconciliation between Safety and Clinical Databases
Vicki Lu
2013 (Boston) Annual Meeting
Contributed Session
Missing Data in Clinical Trials
Erica Love
2013 (Boston) Annual Meeting
Contributed Session
MONITORING COMPLIANCE ON CANCER CLINICAL TRIALS: A PEER REVIEW MECHANISM FOR CONTINUOUS QUALITY IMPROVEMENT
Jye-Yu Backlund
2013 (Boston) Annual Meeting
Contributed Session
Morbidity Adjudication and Tracking during DCCT/EDIC
Elena Biffi
2013 (Boston) Annual Meeting
Contributed Session
Morphologic characteristics of different types of drusen as revealed by SD-OCT
Christopher Crean
2013 (Boston) Annual Meeting
Contributed Session
MULTIPLE PHARMACOKINETIC ASSESSMENTS OF FIVE UNIQUE FORMULATIONS OF EZOGABINE/RETIGABINE COMPARED WITH THE IMMEDIATE RELEASE FORMULATION
Yunzhi Lin
2013 (Boston) Annual Meeting
Contributed Session
Multiple Testing in Clinical Trials: Some New Applications
Kenneth Clark
2013 (Boston) Annual Meeting
Contributed Session
National Lung Screening Trial (NLST): Post-Trial Data and Image Exploration with an Open Source Query Tool
Claire Cocharan
2013 (Boston) Annual Meeting
Contributed Session
No Collaboration, No Trial: Why Collaborator Opinion Matters.
Toshinori Murayama
2013 (Boston) Annual Meeting
Contributed Session
No-fault compensation to participants in un-notified clinical trials including stem cell study in Japan
Syed Aakhtar Bokhari
2013 (Boston) Annual Meeting
Contributed Session
Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial
John Kloke
2013 (Boston) Annual Meeting
Contributed Session
Nonparametric Covariate-Adjusted Hypothesis Tests Using R Estimation
Maria Abraham
2013 (Boston) Annual Meeting
Contributed Session
ON THE ANALYSIS OF TUBERCULOSIS STUDIES WITH MISSING SPUTUM DATA
Jennifer Talton
2013 (Boston) Annual Meeting
Contributed Session
ONLINE REQUEST SYSTEM FOR DATASETS, WRITING GROUPS, AND ANCILLARY STUDIES FOR THE SEARCH FOR DIABETES IN YOUTH STUDY
Sherrie Whisler
2013 (Boston) Annual Meeting
Contributed Session
Overview Focus and Drilldown – Data Report Intelligence
Katherine Freier
2013 (Boston) Annual Meeting
Contributed Session
Paint me a picture: Using visual data representation to summarize and explore data
Ryan Ferguson
2013 (Boston) Annual Meeting
Contributed Session
Patient and Provider Acceptance of a Pragmatic Point-of-Care Pilot Study
Russell Reeve
2013 (Boston) Annual Meeting
Contributed Session
PERSONALIZED AND ADAPTIVE TRIALS IN PHASE 2: COMPARISON OF DESIGNS
Caitlyn Ellerbe
2013 (Boston) Annual Meeting
Contributed Session
Phase II/III Seamless Adaptive Dose Selection Design for Longitudinal Patient Data
Huitian Lei
2013 (Boston) Annual Meeting
Contributed Session
Power analysis and Sample Size Calculation in Designing a SMART Trial for Building Dynamic Treatment Regimens
Qian Wu
2013 (Boston) Annual Meeting
Contributed Session
Power analysis for seamless phase II/III designs with subpopulation selection and a change of survival, binary and normal endpoints
Michele Melia
2013 (Boston) Annual Meeting
Contributed Session
POWER FOR THE PARTIALLY-PAIRED RANDOMIZATION DESIGN AS COMPARED WITH THE UNPAIRED DESIGN IN OPHTHALMOLOGICAL CLINICAL TRIALS
Giada Morpurgo
2013 (Boston) Annual Meeting
Contributed Session
Practical considerations on medical device clinical trials in Georgia, a former Soviet Union country
Mei Lu
2013 (Boston) Annual Meeting
Contributed Session
Pragmatic seamless design for an efficacy trial of asthma management with reduced cost.
Shaun Treweek
2013 (Boston) Annual Meeting
Contributed Session
PRECIS-2: a tool to improve the applicability of randomised controlled trials
Rick Morrison
2013 (Boston) Annual Meeting
Contributed Session
Pulling the Trigger on Risk-based Monitoring
Jenny Donovan
2013 (Boston) Annual Meeting
Contributed Session
Q-QAT (Quanti-Qualitative Appointment Timing): A simple technique to elucidate key recruitment issues in RCTs
Steven Ramsey
2013 (Boston) Annual Meeting
Contributed Session
Quality Control (QC) of Field-Based Pulmonary Function Testing (PFT) in the Gulf Long-Term Follow-up Study (GuLF STUDY)
Kunaal Dhingra
2013 (Boston) Annual Meeting
Contributed Session
Quality of reporting of randomized clinical trials assessing probiotics for periodontal treatment. A systematic review on critical aspects in design, outcome assessment and clinical relevance
Bruckner Thomas
2013 (Boston) Annual Meeting
Contributed Session
Quantile Regression
Dean Gittleman
2013 (Boston) Annual Meeting
Contributed Session
Quantum Leap - Leveraging Real-time (Direct) Data-Entry to Increase Speed, Improve Quality, and Dramatically Reduce Costs
Dennis Sweitzer
2013 (Boston) Annual Meeting
Contributed Session
Randomization Metrics: Jointly assessing predictability and efficiency loss in randomization designs
Catherine Klersy
2013 (Boston) Annual Meeting
Contributed Session
Randomized phase II trials: are they entering research practice?
Adam Glassman
2013 (Boston) Annual Meeting
Contributed Session
Randomizing Two Study Eyes from the Same Participant in Ophthalmic Clinical Trials
Howard Collier
2013 (Boston) Annual Meeting
Contributed Session
Recommendations for future patient focussed trials addressing foot pain in systemic sclerosis
R. Lakshmi Vishnuvajjala
2013 (Boston) Annual Meeting
Contributed Session
Regulatory Issues for Companion Diagnostics
Paul Thompson
2013 (Boston) Annual Meeting
Contributed Session
Reproducible research methods with the SAS system and Microsoft Word
David Swanson
2013 (Boston) Annual Meeting
Contributed Session
Research participant compensation: an issue of inference as well as ethics
Kyra Garofolo
2013 (Boston) Annual Meeting
Contributed Session
Responder Analysis Outcomes in the Analysis of Acute Stroke Clinical Trials
Mitchell Thomann
2013 (Boston) Annual Meeting
Contributed Session
Response-Adaptive Dose-Finding for Correlated Bivariate Data with Applications to Complement System Inhibition Studies
Yuko Palesch
2013 (Boston) Annual Meeting
Contributed Session
Revisiting the question: To adjust or not to adjust for baseline covariates in randomization and/or in analysis of clinical trials?
CHENGWU YANG
2013 (Boston) Annual Meeting
Contributed Session
RISK OF USING INSTRUMENTS IN INTERNATIONAL CLINICAL TRIALS: THE SCORES MAY NOT BE COMPARABLE ACROSS DIFFERENT COUNTRIES
Wenle Zhao
2013 (Boston) Annual Meeting
Contributed Session
Risk-Based Monitoring Approach in Practice – Combination of Real-Time Central Monitoring and On-Site Source Document Verification
Kyle Rudser
2013 (Boston) Annual Meeting
Contributed Session
Sample Size and Screening Size Trade Off in the Presence of Subgroups with Different Expected Treatment Effects
Qiang Zhang
2013 (Boston) Annual Meeting
Contributed Session
Seamless phase II/III design for oncology trials with treatment selection and a change of survival endpoints
Katharine Poole
2013 (Boston) Annual Meeting
Contributed Session
Signal Detection in Small Safety Databases
Mohamed Mubasher
2013 (Boston) Annual Meeting
Contributed Session
SIMULATION-BASED EVALUATIONS OF METHODOLOGICAL ALTERNATIVES FOR RECYCLING RANDOMIZATION ASSIGNMENTS IN RANDOMIZED CLINICAL TRIALS (RCTs) OF ACUTE CONDITIONS (AC) WITH BRIEF FOLLOW UP
Abress Gailor
2013 (Boston) Annual Meeting
Contributed Session
Smaller sample sizes for phase II trials based on exact tests
Marisa De Rosa
2013 (Boston) Annual Meeting
Contributed Session
SMARTLAB: cloud computing for integration of centralized diagnostic laboratory data and patients data collection of research groups
Evan Hempel
2013 (Boston) Annual Meeting
Contributed Session
SOCIAL MEDIA IN CLINICAL TRIAL RECRUITMENT AND RETENTION
Keiko Ohta
2013 (Boston) Annual Meeting
Contributed Session
Standardized the way to management queries without relying data capturing or cleaning systems
Louise Flanagan
2013 (Boston) Annual Meeting
Contributed Session
Standardizing Early Phase Trial Documentation and Processes
Kousick Biswas
2013 (Boston) Annual Meeting
Contributed Session
Statistical Modeling of Recruitment for Multi-site Clinical Trials – Current Status
Kathryn Mangoff
2013 (Boston) Annual Meeting
Contributed Session
STRATEGIES IMPLEMENTED TO ENSURE KNOWLEDGE TRANSFER
Jitendra Ganju
2013 (Boston) Annual Meeting
Contributed Session
Strengthening Inferences from Analysis of Clinical Trial Data
Mark McIlduff
2013 (Boston) Annual Meeting
Contributed Session
Succeeding as a Data Expert at an FDA Advisory Committee Meeting
Dario Gregori
2013 (Boston) Annual Meeting
Contributed Session
Switching from non-inferiority to superiority in an adaptive setting: some notes
Valerie Brueton
2013 (Boston) Annual Meeting
Contributed Session
Systematic review of strategies to reduce attrition in randomised trials
Martin Tickle
2013 (Boston) Annual Meeting
Contributed Session
Systematic reviews or relevant randomised control trials, which should I believe? A dilemma for policy makers
Lucy McParland
2013 (Boston) Annual Meeting
Contributed Session
THE BENEFITS AND CHALLENGES OF PERFORMING A CENTRAL REVIEW OF RESPONSE IN A CHRONIC LYMPHOCYTIC LEUKAEMIA TRIAL
Lawrence Mbuagbaw
2013 (Boston) Annual Meeting
Contributed Session
The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy
Benjamin Saville
2013 (Boston) Annual Meeting
Contributed Session
The case for Bayesian predictive probabilities for interim monitoring of clinical trials
Harlan Campbell
2013 (Boston) Annual Meeting
Contributed Session
The consequences of proportional-hazards based model selection
Barbara Farrell
2013 (Boston) Annual Meeting
Contributed Session
The CORONIS Trial: International study of caesarean section surgical techniques – a randomised non-regular fractional, factorial trial
James Peugh
2013 (Boston) Annual Meeting
Contributed Session
The Effect of Compliance Cut-Points on CACE Treatment Effect Estimates
Sunny Chan
2013 (Boston) Annual Meeting
Contributed Session
The Effect of the Transition from Paper-based to Electronic Data Capture on Clinical Trial Metadata
Norberto Pantoja-Galicia
2013 (Boston) Annual Meeting
Contributed Session
The Evaluation of Medical Diagnostic Tests in Clinical Studies using Local Likelihood Density estimation and ROC curves
Christina Tittsworth
2013 (Boston) Annual Meeting
Contributed Session
The Evolution of the CRF Designer into a Data Manager
Sue Ross
2013 (Boston) Annual Meeting
Contributed Session
The impact of commercial decisions on surgical progress: the case of TVT Secur
Jason Stock
2013 (Boston) Annual Meeting
Contributed Session
The Importance of Innovative Data Management Practices for Clinical Registries
Kimberly Lane
2013 (Boston) Annual Meeting
Contributed Session
The NIH Health Care Systems Research Collaboratory Distributed Research Network
Haruko Yamamoto
2013 (Boston) Annual Meeting
Contributed Session
The path to a global clinical trial for acute stroke in Japan
Steffanie Halberstadt
2013 (Boston) Annual Meeting
Contributed Session
The Potential of the Poincare Plot in the Search for Meaningful Measures of Heart Rate Variability
Louise Flanagan
2013 (Boston) Annual Meeting
Contributed Session
The Risks and Benefits Associated with Running Investigator Led Early Phase Trials in Collaboration with Pharmaceutical and Charity Partners
Aaron Perlmutter
2013 (Boston) Annual Meeting
Contributed Session
THE ROLE OF THE DATA MANAGER IN RISK-BASED MONITORING
Tae-Yong Park
2013 (Boston) Annual Meeting
Contributed Session
The Sensitivity and Positive Predictive Value of Stroke Pattern Indicators in Traditional Korean Medicine: The Korean Standard Pattern Identification Questionnaire for Stroke
Lea Drye
2013 (Boston) Annual Meeting
Contributed Session
The transforming of multicenter clinical trials to observational follow-up studies
Haijing Qin
2013 (Boston) Annual Meeting
Contributed Session
THE USE OF A WEIGHTED COMBINATION OF THE LIFE-TABLE SURVIVAL ESTIMATES TO EVALUATE THE TREATMENT EFFECT IN A RANDOMIZED CLINICAL TRIAL WHEN THE PROPORTIONAL HAZARDS ASSUMPTION IS VIOLATED
Aquila Farrell
2013 (Boston) Annual Meeting
Contributed Session
THE USE OF LOGS AND FORMS FOR THE TRACKING OF RT-CGM DEVICES IN THE CONCEPTT TRIAL
Vivek Murthy
2013 (Boston) Annual Meeting
Contributed Session
The Use of Site Engagement Technology (SET) to Increase Patient Recruitment and Retention in Clinical Trials: a Case Study
Farrah Mateen
2013 (Boston) Annual Meeting
Contributed Session
Titles versus Titles-and-Abstracts for Initial Screening of Articles for Systematic Reviews
Holly Battenhouse
2013 (Boston) Annual Meeting
Contributed Session
Transitioning data management systems during an ongoing study: challenges, limitations and successes
Catherine Dillon
2013 (Boston) Annual Meeting
Contributed Session
Trial Operation Errors: Sources and Prevention
Stacey Slone
2013 (Boston) Annual Meeting
Contributed Session
Tricks of the Trade: Using SAS® to Analyze Irregularly Scheduled Clinical Data
Jenny Donovan
2013 (Boston) Annual Meeting
Contributed Session
Understanding recruitment to randomised controlled trials: clinician and triallist perspectives
Wenle Zhao
2013 (Boston) Annual Meeting
Contributed Session
Unintentional operation mistakes in emergency treatment trials and their impacts on trial results
Annalisa Perna
2013 (Boston) Annual Meeting
Contributed Session
USE OF JOINT MODELING FOR LONGITUDINAL AND SURVIVAL DATA IN LONG-TERM RENAL CLINICAL TRIALS
Heather Litman
2013 (Boston) Annual Meeting
Contributed Session
USE OF PROPENSITY SCORES TO COMBINE DATA FROM TWO SIMILAR CLINICAL TRIALS IN THE URINARY INCONTINENCE TREATMENT NETWORK
Geraldine Baggs
2013 (Boston) Annual Meeting
Contributed Session
Using a Global Outcome (Sum of Pre-Post Ratings) in Ascertaining Effect of an Intervention
Laurie McLeod
2013 (Boston) Annual Meeting
Contributed Session
USING A WEBPORTAL TO ENHANCE NETWORK COMMUNICATION
John Norrie
2013 (Boston) Annual Meeting
Contributed Session
Using adaptive designs to build a behaviour change intervention in a complex intervention randomised controlled trial
John Norrie
2013 (Boston) Annual Meeting
Contributed Session
Using adaptive designs to build a behavioural change intervention in a complex intervention randomised controlled trial
Sarah Brown
2013 (Boston) Annual Meeting
Contributed Session
Using central review data in analyses of phase III trials
Miguel Villarreal
2013 (Boston) Annual Meeting
Contributed Session
UTILIZING R FOR THE GRAPHICAL REPORTING OF ADVERSE EVENT CLINICAL TRIAL DATA TO FACILITATE DSMB REVIEW
Patricia Davis
2013 (Boston) Annual Meeting
Contributed Session
WEB-BASED ADMINISTRATION AND TRACKING OF COGNITIVE DATA IN THE ACCORDION-MIND STUDY
Shaun Treweek
2013 (Boston) Annual Meeting
Contributed Session
Web-based intervention modelling experiments: a way of exploring professional behaviour change interventions before a full-scale trial.
Marion Campbell
2013 (Boston) Annual Meeting
Contributed Session
WHAT MAKES PEOPLE PARTICIPATE IN CLINICAL TRIALS? INSIGHTS FROM A META-ETHNOGRAPHY OF QUALITATIVE STUDIES
Aenne Glass
2013 (Boston) Annual Meeting
Contributed Session
WHEN SURVIVAL CURVES CROSS … ADD A LANDMARK ANALYSIS: AN EXAMPLE FROM CARDIOLOGY
Perkins John
2013 (Boston) Annual Meeting
Contributed Session
WHISpERer: Integrated Team Approach to Declarative Study Specification